Processa Pharmaceuticals, Inc. (PCSA) DCF Valuation

Processa Pharmaceuticals, Inc. (PCSA) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Processa Pharmaceuticals, Inc. (PCSA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Engineered for accuracy, our (PCSA) DCF Calculator empowers you to evaluate Processa Pharmaceuticals, Inc. valuation using actual financial data, offering complete flexibility to modify all essential parameters for enhanced projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -3.0 -5.6 -11.1 -19.5 -11.5 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .9 .9 .9 .9 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -3.9 -6.5 -12.0 -20.3 -11.5 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .7 15.4 16.5 6.5 4.7 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .2 .1 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .1 .3 .2 .3 .3 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -3.3 -6.1 -11.4 -40.7 -11.5 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -2.4 -5.2 -10.5 -39.6 -11.5 -.3 .0 .0 .0 .0
WACC, % 6.88 6.92 6.93 6.95 6.95 6.93 6.93 6.93 6.93 6.93
PV UFCF
SUM PV UFCF -.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -5
Equity Value 4
Diluted Shares Outstanding, MM 1
Equity Value Per Share 3.25

What You Will Receive

  • Pre-Filled Financial Model: Processa Pharmaceuticals' actual data allows for accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Real-Time Calculations: Automatic updates provide instant feedback as you adjust inputs.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
  • Customizable and Reusable: Designed for versatility, enabling ongoing use for in-depth forecasts.

Key Features

  • Customizable Clinical Parameters: Adjust essential inputs such as patient demographics, treatment efficacy, and cost projections.
  • Instant DCF Valuation: Quickly computes intrinsic value, NPV, and additional metrics with ease.
  • High-Precision Accuracy: Utilizes real-world financial data from Processa Pharmaceuticals for dependable valuation results.
  • Effortless Scenario Analysis: Evaluate various assumptions and effortlessly compare results.
  • Efficiency Booster: Remove the complexity of developing detailed valuation models from the ground up.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based PCSA DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically calculates Processa Pharmaceuticals’ intrinsic value.
  4. Test Scenarios: Experiment with different assumptions to see how they affect the valuation.
  5. Analyze and Decide: Utilize the output to inform your investment or financial strategy.

Why Choose This Calculator for Processa Pharmaceuticals, Inc. (PCSA)?

  • Accurate Data: Utilize real financial metrics from Processa Pharmaceuticals for dependable valuation outcomes.
  • Customizable: Tailor critical inputs such as growth projections, WACC, and tax rates to align with your expectations.
  • Time-Saving: Ready-to-use calculations streamline your analysis process.
  • Professional-Grade Tool: Crafted for investors, analysts, and industry consultants.
  • User-Friendly: Designed with an intuitive interface and clear instructions to accommodate users of all levels.

Who Should Use Processa Pharmaceuticals, Inc. (PCSA)?

  • Investors: Gain insights into the pharmaceutical market with a reliable investment analysis tool.
  • Financial Analysts: Streamline your workflow with a comprehensive model tailored for pharmaceutical evaluations.
  • Consultants: Effortlessly modify the framework for client discussions or industry reports.
  • Pharmaceutical Enthusiasts: Enhance your knowledge of drug development processes and market dynamics through practical examples.
  • Educators and Students: Utilize it as a hands-on resource in courses related to pharmaceuticals and finance.

What the Template Contains

  • Comprehensive DCF Model: Editable template featuring intricate valuation calculations tailored for Processa Pharmaceuticals, Inc. (PCSA).
  • Real-World Data: Historical and projected financials for Processa Pharmaceuticals preloaded for in-depth analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns to provide deeper insights into financial performance.
  • Key Ratios: Integrated analysis for assessing profitability, efficiency, and leverage specific to Processa Pharmaceuticals.
  • Dashboard with Visual Outputs: Charts and tables designed for clear and actionable results.

Es wurden keine passenden Produkte gefunden.